In a historic move, the United States Food and Drug Administration (USFDA) has approved the first gel-based, non-hormonal female contraceptive. This novel formulation was designed for use as an “on-demand” method of contraception and demonstrated high efficacy rates in clinical trials. In a revolutionary breakthrough, the USFDA has approved the launch of a non-hormonal gel contraceptive, which mechanizes in a unique way to prevent unwanted pregnancies. It is an amalgamation of lactic acid, citric acid, and potassium bitartrate.
This vaginal pH regulator (VPR) is indicated for use as an “on-demand” method of contraception. The table below illustrates the characteristics of the VPR in brief. Table 1: Characteristics of the VPR Generic name Lactic acid, citric acid, and potassium bitartrate vaginal gel Class of drug Vaginal pH regulator (VPR) Dosage form and strengths One pre-filled,…
